共 50 条
- [1] GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4 HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 63 - 64
- [2] Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1700 - E1709
- [3] Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : 1357 - 1367
- [4] Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1847 - E1861
- [6] Once-Weekly Somapacitan versus Daily GH in Children with GH Deficiency: The Randomized Phase 3 REAL 4 Trial HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 277 - 277
- [7] Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : 3378 - 3388
- [8] Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH (05 Jul, 10.1210/clinem/dgad394, 2023) JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1688 - E1688
- [9] Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1358 - E1376
- [10] Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 87 - 87